¹⁸F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer

Abstract

In patients with high-risk prostate cancer, FCH PET and FCH PET/WBMRI depict significantly more metastatic lesions than do conventional imaging and WBMRI. Stage determined with PET/WBMRI may correlate with early outcomes.